Skip to main content
Livermore
Livermore
ZHEN

Enzo Biochem Inc

ENZBDelisted Apr 7, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000316253

Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Enzo Biochem Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+5 vs. Q3 2022
Shares held
18.8M
−359.6K (−1.9%) vs. Q3 2022
Total value
$26.8M
−$15.8M (−37.1%) vs. Q3 2022
New holders
8
10 more added
Sold out
3
13 more reduced

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 52 institutions
Q1 2021: 82 institutionsQ2 2021: 72 institutionsQ3 2021: 65 institutionsQ4 2021: 59 institutionsQ1 2022: 51 institutionsQ2 2022: 54 institutionsQ3 2022: 49 institutionsQ4 2022: 52 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 39 institutionsQ4 2023: 46 institutionsQ1 2024: 41 institutionsQ2 2024: 39 institutionsQ3 2024: 43 institutionsQ4 2024: 44 institutionsQ1 2025: 41 institutionsQ2 2025: 7 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $26.8M
Q1 2021: $94.6MQ2 2021: $76.6MQ3 2021: $82.9MQ4 2021: $69.0MQ1 2022: $62.0MQ2 2022: $43.8MQ3 2022: $45.6MQ4 2022: $26.8MQ1 2023: $48.1MQ2 2023: $34.7MQ3 2023: $23.1MQ4 2023: $22.7MQ1 2024: $17.6MQ2 2024: $13.5MQ3 2024: $14.2MQ4 2024: $9.71MQ1 2025: $4.96MQ2 2025: $2.00MQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ENZB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20257$2.00M
Q1 202541$4.96M
Q4 202444$9.71M
Q3 202443$14.2M
Q2 202439$13.5M
Q1 202441$17.6M
Q4 202346$22.7M
Q3 202339$23.1M
Q2 202347$34.7M
Q1 202352$48.1M
Q4 202252$26.8M
Q3 202249$45.6M
Q2 202254$43.8M
Q1 202251$62.0M
Q4 202159$69.0M
Q3 202165$82.9M
Q2 202172$76.6M
Q1 202182$94.6M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q3 2022.

Institutions holding ENZB in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Benjamin Edwards Inc300$00.00%00.0%Unchanged
JPMorgan Chase & Co70$00.00%00.0%Unchanged
GWM Advisors LLC10$00.00%+10New
Focused Wealth Management, Inc110$1570.00%00.0%Unchanged
City Holding Co120$1700.00%00.0%Unchanged
Federated Hermes, Inc.132$1890.00%00.0%Unchanged
Advisory Services Network, LLC500$7150.00%+500New
FMR LLC518$7410.00%00.0%Unchanged
Corrado Advisors, LLC550$7860.00%+550New
Advisor Group Holdings, Inc.728$1.00K0.00%00.0%Unchanged
Royal Bank of Canada1,000$1.00K0.00%+500+100.0%Added
UBS Group AG1,353$1.94K0.00%+1,353New
Bank of America Corp3,131$4.48K0.00%−2,898−48.1%Reduced
Wells Fargo & Company3,892$5.57K0.00%+2,436+167.3%Added
BDO Wealth Advisors, LLC5,000$7.15K0.00%00.0%Unchanged
Wealth Alliance11,433$16.3K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc13,471$19.3K0.00%00.0%Unchanged
Baird Financial Group, Inc.15,000$21.0K0.00%00.0%Unchanged
Shulman DeMeo Asset Management LLC15,487$22.1K0.01%00.0%Unchanged
Agate Pass Investment Management, LLC16,292$23.3K0.02%+16,292New
Raymond James Trust N.A.17,016$24.0K0.00%00.0%Unchanged
Cutter & CO Brokerage, Inc.17,706$25.3K0.01%−4,071−18.7%Reduced
Paradigm Financial Partners, LLC18,500$25.9K0.01%+500+2.8%Added
Prudential Financial Inc18,200$26.0K0.00%00.0%Unchanged
AE Wealth Management LLC20,000$28.6K0.00%00.0%Unchanged
Wolverine Trading, LLC21,266$30.0K0.00%+21,266New
Kempner Capital Management Inc.25,475$36.4K0.02%00.0%Unchanged
Tower Research Capital LLC (TRC)26,056$37.0K0.00%+224+0.9%Added
Bank of New York Mellon Corp26,217$37.5K0.00%−61,064−70.0%Reduced
Group One Trading, L.P.27,996$40.0K0.00%−23,598−45.7%Reduced
Susquehanna International Group, LLP28,228$40.4K0.00%+28,228New
Snowden Capital Advisors LLC29,104$41.6K0.00%−2,600−8.2%Reduced
Belvedere Trading LLC35,350$50.5K0.03%+35,350New
Price T Rowe Associates Inc44,800$64.0K0.00%00.0%Unchanged
SNS Financial Group, LLC62,500$89.4K0.01%00.0%Unchanged
Citadel Advisors LLC62,776$89.8K0.00%+44,585+245.1%Added
Corsair Capital Management, L.P.66,601$95.2K0.04%−8,448−11.3%Reduced
Simplex Trading, LLC71,871$102.0K0.00%+44,140+159.2%Added
Northern Trust Corp103,736$148.3K0.00%−332−0.3%Reduced
State Street Corp184,139$263.3K0.00%−1,500−0.8%Reduced
RBF Capital, LLC250,359$359.0K0.03%00.0%Unchanged
Bridgeway Capital Management, LLC320,700$458.6K0.01%00.0%Unchanged
Geode Capital Management, LLC352,848$504.0K0.00%−4,696−1.3%Reduced
Morgan Stanley367,302$525.2K0.00%−21,896−5.6%Reduced
Potomac Capital Management, Inc.569,000$814.0K1.13%+9,500+1.7%Added
Fuller & Thaler Asset Management, Inc.983,285$1.41M0.01%+12,275+1.3%Added
BlackRock Inc.1,425,807$2.04M0.00%−42,314−2.9%Reduced
Dimensional Fund Advisors LP1,614,450$2.31M0.00%+20,585+1.3%Added
Vanguard Group Inc1,771,671$2.53M0.00%+922+0.1%Added
Roumell Asset Management, LLC2,128,264$3.04M7.54%−261,947−11.0%Reduced
Renaissance Technologies LLC2,813,964$4.02M0.01%−95,700−3.3%Reduced
Harbert Fund Advisors, Inc.5,175,913$7.40M6.38%00.0%Unchanged
Truist Financial Corp0$00.00%−50,016−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−17,473−100.0%Sold out
Hudock, Inc.0$00.00%−242−100.0%Sold out
VIEX Capital Advisors, LLC––––Not filed
FourThought Financial, LLC––––Not filed